PADs are known to have critical roles in infection, with effective PAD inhibitor treatment in sepsis and endotoxemia including by inhibition of NETosis [91,92,93] and effects on bacterial EV release and antibiotic treatment sensitisation [94]. Here, PADI4 is linked to serum lipopolysaccharide activity.